Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 58Carcinoma, Hepatocellular 28Breast Neoplasms 26Small Cell Lung Carcinoma 20Lung Neoplasms 20Triple Negative Breast Neoplasms 18Urinary Bladder Neoplasms 17Neoplasms 16Carcinoma, Transitional Cell 16Neoplasm Metastasis 15Melanoma 15Colorectal Neoplasms 15Uterine Cervical Neoplasms 11Carcinoma, Renal Cell 10Stomach Neoplasms 7Recurrence 7Head and Neck Neoplasms 7Prostatic Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Mesothelioma, Malignant 5Liver Neoplasms 5Carcinoma, Squamous Cell 5Ovarian Neoplasms 4Esophageal Neoplasms 4Carcinoma, Merkel Cell 4Biliary Tract Neoplasms 4Urethral Neoplasms 3Ureteral Neoplasms 3Thoracic Neoplasms 3

Interventions

atezolizumab 2Etoposide 2Carboplatin 2talazoparib 1olaparib 1lipoarabinomannan 1cediranib 1Specimen Handling 1Platinum 1Magnetic Resonance Spectroscopy 1Lamivudine 1Cisplatin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Extensive Stage Lung Small Cell Carcinoma × atezolizumab × Clear all
NCT04334941 2026-06-05

Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

National Cancer Institute (NCI)

Phase 2 Active not recruiting
103 enrolled

Extensive Stage Lung Small Cell Carcinoma

NCT04696575 2025-12-15

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 2 Recruiting
28 enrolled

Extensive Stage Lung Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡